Partnerships & Mergers
-
Saudi German Health designates DataFlow Group as official primary source verification partner
Under the agreement, SGH-referred healthcare practitioners will have access to DataFlow’s range of services, including Premium PSV, VIP Assist, Document Concierge, licensing and credentialing support, digital footprint checks and Prometric nursing exam training.
-
Saudi German Hospital Alexandria collaborates with Conceive Center to establish fertility care partnership in Egypt
The partnership comes as Egypt seeks to attract more patients from Arab and African markets by capitalising on its healthcare advantages.
-
Jasper Secures US$132 M Private Placement Following Kira Pharmaceuticals Takeover
Following the transaction, former Kira shareholders will own nearly 50% of the combined company, new private financing investors will hold slightly more than 43%, and existing Jasper shareholders will retain almost 7%.
-
Polaroid Therapeutics joins Crohn’s & Colitis Foundation’s IBD Plexus to advance IBD research
Through its membership, PTx will gain access to longitudinal health data and biosamples from people living with IBD, with personal identifying information removed.
-
Jeddah Health Cluster 2 collaborates with Jamjoom Pharma to advance healthcare in Saudi Arabia
Through this collaboration, both organisations will work to improve patient care by supporting healthcare professionals with access to the latest medical knowledge and best practices.
-
US hands over US$2.2M health package to support disease prevention in Madagascar
The assistance forms part of a wider U.S.-Madagascar health partnership established under the bilateral Global Health Memorandum of Understanding (MOU) signed in December 2025.
-
Gulf Medical University signs Swiss academic agreement to pioneer longevity training
The partnership combines GCLS’s expertise as the world’s first higher education institution dedicated exclusively to longevity science with GMU’s academic resources and Thumbay Healthcare’s extensive clinical network across the region.
-
Evogene collaborates with Blavatnik Center to advance Israeli biotech ecosystem
Under the agreement, researchers will gain access to an integrated platform that combines Evogene’s AI-powered computational chemistry engine, ChemPass AI, with the BCDD’s laboratory infrastructure and drug discovery expertise.
-
Novo Nordisk collaborates with Vivani Medical to evaluate semaglutide implant for chronic weight management
Under the agreement, Novo Nordisk will internally assess Vivani’s investigational NPM-139 implant, which utilizes the company’s proprietary NanoPortal technology to deliver semaglutide continuously over extended periods through a miniature subdermal device.
-
AstraZeneca strengthens CSPC alliance with US$1.77B kidney disease drug discovery deal
The new collaboration centres on CSPC’s small interfering RNA (siRNA) drug discovery platform and its proprietary delivery technology, which is designed to transport therapies beyond the liver.